09.06.2014 14:27:42
|
Bristol-Myers Squibb Appoints Giovanni Caforio COO - Quick Facts
(RTTNews) - Bristol-Myers Squibb Co.(BMY) Monday named Giovanni Caforio as its chief operating officer, and was elected to the board, effective June 5, 2014.
In addition to his current role as chief commercial officer, Caforio will add leadership responsibility for the company-wide functions of Enterprise Services and Global Manufacturing & Supply, said the company. He will continue to report to Chief Executive, Lamberto Andreotti.
Caforio joined the company in 2000 as vice president and general manager, Italy, and served in leadership roles for Greece, South East Europe, and in 2004, was named senior vice president of European Marketing and Brand Commercialization. Earlier to joining Bristol-Myers, Caforio spent 12 years in Abbott Laboratories. (ABT)

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Bristol-Myers Squibb Co.mehr Nachrichten
Analysen zu Bristol-Myers Squibb Co.mehr Analysen
Aktien in diesem Artikel
Bristol-Myers Squibb Co. | 55,33 | -0,25% |
|